FDA label
What is Nuplazid used for?
Nuplazid contains pimavanserin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Nuplazid?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Nuplazid, tablet, coated
Indications and Usage, quoted from the label by Acadia Pharmaceuticals Inc. (NDA207318). Cross-references to other label sections are left out.
NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
Source: DailyMed label, set id 1e6bea44-57d6-4bac-9328-46e1ee59f83b, version 23, effective June 18, 2026. NDC 63090-100, one of 1 listing for this product.
Questions
What is Nuplazid used for?
The FDA label says: “NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.”
What drug class is Nuplazid?
FDA lists pimavanserin in the Atypical Antipsychotic established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.